Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - aspirin,dipyridamole -

USA - engelsk - NLM (National Library of Medicine)

innovida phamaceutique corporation - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - aspirin and omeprazole delayed-release tablets, a combination of aspirin and omeprazole, is indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers. the aspirin component of aspirin and omeprazole delayed-release tablets is indicated for: - reducing the combined risk of death and nonfatal stroke in patients who have had ischemic stroke or transient ischemia of the brain due to fibrin platelet emboli, - reducing the combined risk of death and nonfatal mi in patients with a previous mi or unstable angina pectoris, - reducing the combined risk of mi and sudden death in patients with chronic stable angina pectoris, - use in patients who have undergone revascularization procedures (coronary artery bypass graft [cabg] or percutaneous transluminal coronary angioplasty [ptca]) when there is a pre-existing condition for which aspirin is already indicated. the omeprazole component of aspirin and

USA - engelsk - NLM (National Library of Medicine)

innovida therapeutique corporation - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - aspirin and omeprazole delayed-release tabletsa, a combination of aspirin and omeprazole, is indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers. the aspirin component of aspirin and omeprazole delayed-release tabletsa is indicated for: - reducing the combined risk of death and nonfatal stroke in patients who have had ischemic stroke or transient ischemia of the brain due to fibrin platelet emboli, - reducing the combined risk of death and nonfatal mi in patients with a previous mi or unstable angina pectoris, - reducing the combined risk of mi and sudden death in patients with chronic stable angina pectoris, - use in patients who have undergone revascularization procedures (coronary artery bypass graft [cabg] or percutaneous transluminal coronary angioplasty [ptca]) when there is a pre-existing condition for which aspirin is already indicated. the omeprazole component of aspirin an

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - aspirin,clopidogrel hydrogen sulfate -

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer sa-nv - acide acétylsalicylique 100 mg - comprimé gastro-résistant - 100 mg - acide acétylsalicylique 100 mg - acetylsalicylic acid

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer sa-nv - acetylsalicylzuur 100 mg - maagsapresistente tablet - 100 mg - acetylsalicylzuur 100 mg - acetylsalicylic acid

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

medreich new zealand limited - aspirin 100mg (as aspirin rhodine 2368 111.12 mg (aspirin 100.008 + maize starch 1.112)) - enteric coated tablet - 100 mg - active: aspirin 100mg (as aspirin rhodine 2368 111.12 mg (aspirin 100.008 + maize starch 1.112)) excipient: betadex carbomer citric acid hypromellose macrogol 6000 methacrylic acid copolymer microcrystalline cellulose opadry white oy-b-28920 amb pregelatinised maize starch purified talc sodium hydroxide stearic acid sunset yellow fcf titanium dioxide - reduces the risk of heart attack and stroke in patients with known cardiovascular or cerebrovascular disease, by helping to prevent blood clotting.

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - aspirin - oral capsule - 100mg

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

multichem nz limited - aspirin 100mg;   - enteric coated tablet - 100 mg - active: aspirin 100mg   excipient: colloidal silicon dioxide hypromellose iron oxide red methacrylic acid copolymer pregelatinised maize starch purified talc purified water   stearic acid titanium dioxide triethyl citrate

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

multichem nz limited - aspirin 100mg;   - enteric coated tablet - 100 mg - active: aspirin 100mg   excipient: colloidal silicon dioxide hypromellose iron oxide red methacrylic acid copolymer pregelatinised maize starch purified talc purified water   stearic acid titanium dioxide triethyl citrate